ONCO Profile
Onconetix, Inc., headquartered in Cincinnati, Ohio, is a biotechnology and pharmaceutical company dedicated to developing and commercializing transformative therapies to address critical health challenges. Established in 2018, Onconetix focuses on innovative solutions to improve patient outcomes across a range of medical conditions. The company’s flagship product, Entadfi, is an FDA-approved daily oral medication that combines finasteride and tadalafil. This dual-action pill is designed to treat benign prostatic hyperplasia (BPH), offering a novel approach to managing this common urological condition.
In addition to Entadfi, Onconetix is advancing a diverse pipeline of therapeutic candidates. The company is developing a vaccine against Streptococcus pneumoniae, aimed at preventing middle ear infections in children and pneumonia in the elderly. This vaccine represents a significant step forward in addressing serious respiratory infections that pose substantial health risks. Furthermore, Onconetix is working on a universal flu vaccine intended to provide protection against all virulent strains of influenza, potentially revolutionizing flu prevention.
The company has also acquired a novel vaccine platform from Cincinnati Children's Hospital, which utilizes a versatile virus-like particle (VLP) technology. This platform is being employed to develop vaccines for various infectious diseases, including Marburg virus, monkeypox, and others. The VLP technology offers a flexible and robust approach to vaccine development, with the potential to address multiple infectious threats efficiently.
Formerly known as Blue Water Biotech, Inc., Onconetix rebranded to reflect its expanded focus and strategic vision. The company's innovative research and development efforts underscore its commitment to advancing healthcare solutions. With a strong emphasis on transformative therapies and a broad portfolio of development programs, Onconetix is positioned to make significant contributions to the field of biotechnology and pharmaceutical science.
|
